V. Raghavendra et al., MODULATION OF MOTOR FUNCTIONS INVOLVING THE DOPAMINERGIC SYSTEM BY AT(1) RECEPTOR ANTAGONIST, LOSARTAN, Neuropeptides, 32(3), 1998, pp. 275-280
Growing evidence has indicated the existence of a brain renin angioten
sin system and its possible interaction with other putative neurotrans
mitters and their receptors. In the present study, the effect of losar
tan, an AT(1) receptor antagonist, was studied on the motor functions
involving the dopaminergic system. Losartan (5-30 mg/kg) per se decrea
sed locomotor activity without producing motor toxicity. It partially
reversed the apomorphine-induced hyperlocomotion and stereotypy in mic
e, and potentiated neuroleptic-induced catalepsy in rats. On chronic a
dministration (once daily for 21 days) losartan failed to block apomor
phine-induced hyperlocomotion, but the inhibition of stereotypic respo
nse and potentiation of neuroleptic-induced catalepsy remained unalter
ed. These observations suggest that losartan inhibited the release of
dopamine through AT(1) receptor and also suggest the existence of a co
mpensatory mechanism in certain brain region concerned with dopamine m
otor function.